{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:11:30Z","timestamp":1790946690552,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.bcmd.2013.04.006","type":"journal-article","created":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T07:04:52Z","timestamp":1369292692000},"page":"185-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease"],"prefix":"10.1016","volume":"51","author":[{"given":"M.","family":"Reed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2013.04.006_bb0005","first-page":"309","article-title":"The enzymatic defect in Gaucher disease","volume":"95","author":"Brady","year":"1982","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0010","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0950-3536(97)80033-9","article-title":"Gaucher's disease: clinical features and natural history","volume":"10","author":"Cox","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0015","first-page":"205","article-title":"Cytokines in Gaucher's disease","volume":"10","author":"Barak","year":"1999","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10","volume":"90","author":"Allen","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.bcmd.2013.04.006_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11926-000-0059-x","article-title":"Bone and joint complications related to Gaucher disease","volume":"2","author":"Pastores","year":"2000","journal-title":"Curr. Rheumatol. Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.bcmd.2013.04.006_bb0030","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspects of Gaucher disease: a review","volume":"75","author":"Wenstrup","year":"2002","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0035","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/jbmr.5650111125","article-title":"Bone density in Type 1 Gaucher disease","volume":"11","author":"Pastores","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0040","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198509000-00003","article-title":"Skeletal complications of Gaucher disease","volume":"64","author":"Stowens","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bcmd.2013.04.006_bb0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.bor.0000147283.40529.13","article-title":"Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler\u2013Scheie syndrome (mucopolysaccharidosis type I)","volume":"17","author":"Pastores","year":"2005","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2","key":"10.1016\/j.bcmd.2013.04.006_bb0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/scd.2011.0365","article-title":"Bone marrow microenvironment in an in vitro model of Gaucher disease: consequences of glucocerebrosidase deficiency","volume":"21","author":"Lecourt","year":"2012","journal-title":"Stem Cells Dev."},{"issue":"45","key":"10.1016\/j.bcmd.2013.04.006_bb0055","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.bcmd.2013.04.006_bb0060","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.bcmd.2013.04.006_bb0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bcmd.2010.10.011","article-title":"Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults","volume":"46","author":"Mistry","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.1680","article-title":"Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease \u2014 a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry","author":"Khan","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bcmd.2013.04.006_bb0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gene.2012.07.071","article-title":"Induction of osteoclastogenesis in an in vitro model of Gaucher disease is mediated by T cells via TNF-\u03b1","volume":"509","author":"Mucci","year":"2012","journal-title":"Gene"},{"issue":"290","key":"10.1016\/j.bcmd.2013.04.006_bb0080","first-page":"503","article-title":"Treatment of type 1 Gaucher's disease affecting bone with aminohydroxypropylidene bisphosphonate (pamidronate)","volume":"79","author":"Ostlere","year":"1991","journal-title":"Q. J. Med."},{"issue":"5","key":"10.1016\/j.bcmd.2013.04.006_bb0085","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.V96.5.1969","article-title":"Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K","volume":"96","author":"Moran","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.04.006_bb0090","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10545-005-0032-y","article-title":"Gaucher disease and bone: laboratory and skeletal mineral density variations during a long period of enzyme replacement therapy","volume":"28","author":"Ciana","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/bcmd.2001.0479","article-title":"Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease","volume":"28","author":"Drugan","year":"2002","journal-title":"Blood Cells Mol. Dis."},{"issue":"7","key":"10.1016\/j.bcmd.2013.04.006_bb0100","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1210\/jc.2011-0162","article-title":"Markers of bone turnover in Gaucher disease: modeling the evolution of bone disease","volume":"96","author":"van Dussen","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0105","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(95)91038-7","article-title":"Replacement therapy with imiglucerase for type 1 Gaucher's disease","volume":"345","author":"Zimran","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2013.04.006_bb0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1359\/jbmr.061004","article-title":"Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease","volume":"22","author":"Wenstrup","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0120","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00774-004-0529-8","article-title":"Bone density changes with enzyme therapy for Gaucher disease","volume":"22","author":"Lebel","year":"2004","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0125","doi-asserted-by":"crossref","first-page":"43R","DOI":"10.1093\/glycob\/cwi076","article-title":"Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses","volume":"15","author":"Butters","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.bcmd.2013.04.006_bb0130","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.clinthera.2007.08.006","article-title":"Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies","volume":"29","author":"Pastores","year":"2007","journal-title":"Clin. Ther."},{"issue":"20","key":"10.1016\/j.bcmd.2013.04.006_bb0135","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1182\/blood-2010-06-293902","article-title":"Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study","volume":"116","author":"Lukina","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.04.006_bb0140","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/bcmd.2002.0517","article-title":"Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy","volume":"28","author":"Schiffmann","year":"2002","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0145","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1399-0004.2008.00978.x","article-title":"Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study","volume":"73","author":"Sims","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00223-008-9143-4","article-title":"Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustat","volume":"83","author":"Mikosch","year":"2008","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0155","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bone.2008.06.015","article-title":"Pathogenesis of Paget's disease of bone","volume":"43","author":"Ralston","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bcmd.2013.04.006_bb0160","first-page":"943","article-title":"Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis","volume":"152","author":"Gravallese","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jcb.22403","article-title":"Pathogenesis of myeloma bone disease","volume":"109","author":"Roodman","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S8756-3282(00)00345-8","article-title":"Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL","volume":"27","author":"Neale","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bcmd.2013.04.006_bb0175","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI200316069","article-title":"Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis","volume":"111","author":"Ritchlin","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0180","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/bbrc.1998.8586","article-title":"Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures","volume":"246","author":"Matsuzaki","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0185","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1210\/endo.136.2.7835314","article-title":"Macrophage colony-stimulating factor and interleukin-1 alpha maintain the survival of osteoclast-like cells","volume":"136","author":"Jimi","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcmd.2013.04.006_bb0190","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/ard.2007.086066","article-title":"Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis","volume":"68","author":"Kelchtermans","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0195","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1210\/en.2008-0111","article-title":"Modulation of osteoclastogenesis by fatty acids","volume":"149","author":"Cornish","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcmd.2013.04.006_bb0200","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/jcb.21360","article-title":"Activated platelets positively regulate RANKL-mediated osteoclast differentiation","volume":"102","author":"Weicht","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0205","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/bcmd.1999.0237","article-title":"T cell numbers relate to bone involvement in Gaucher disease","volume":"25","author":"Lacerda","year":"1999","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0210","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02411252","article-title":"Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function","volume":"34","author":"Minkin","year":"1982","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0215","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1194\/jlr.M200232-JLR200","article-title":"Glucosylceramide modulates membrane traffic along the endocytic pathway","volume":"43","author":"Sillence","year":"2002","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.bcmd.2013.04.006_bb0220","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1359\/jbmr.1999.14.6.937","article-title":"Macrophage colony stimulating factor increases bone resorption in dispersed osteoclast cultures by increasing osteoclast size","volume":"14","author":"Lees","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0225","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/bcmd.2002.0517","article-title":"Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy","volume":"28","author":"Schiffmann","year":"2002","journal-title":"Blood Cells Mol. Dis."},{"issue":"7","key":"10.1016\/j.bcmd.2013.04.006_bb0230","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.bbadis.2007.04.002","article-title":"Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease","volume":"1772","author":"van Breemen","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2013.04.006_bb0235","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/bcmd.1997.0137","article-title":"Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease","volume":"23","author":"Hollak","year":"1997","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0240","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1172\/JCI110363","article-title":"Selective effects of glucocerebroside (Gaucher's storage material) on macrophage cultures","volume":"68","author":"Gery","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0245","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0250","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2006.05978.x","article-title":"Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease","volume":"133","author":"Magal","year":"2006","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.bcmd.2013.04.006_bb0255","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ymgme.2007.04.001","article-title":"A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease","volume":"91","author":"McEachern","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcmd.2013.04.006_bb0260","doi-asserted-by":"crossref","first-page":"46031","DOI":"10.1074\/jbc.M104464200","article-title":"Lactosylceramide is essential for the osteoclastogenesis mediated by macrophage-colony-stimulating factor and receptor activator of nuclear factor-kappa B ligand","volume":"276","author":"Iwamoto","year":"2001","journal-title":"J. Biol. Chem."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979613000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979613000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:29:17Z","timestamp":1761049757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979613000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1079979613000867"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2013.04.006","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2013.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}